Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 6859523, 10 pages
http://dx.doi.org/10.1155/2016/6859523
Review Article

Mitochondrion-Permeable Antioxidants to Treat ROS-Burst-Mediated Acute Diseases

1College of Resources Science and Technology, Sichuan Agricultural University, Chengdu 611130, China
2College of Bioindustry, Chengdu University, Chengdu 610106, China
3Sichuan Kelun Pharmaceutical Co. Ltd., Chengdu 610071, China

Received 9 April 2015; Revised 9 July 2015; Accepted 14 July 2015

Academic Editor: Luciano Saso

Copyright © 2016 Zhong-Wei Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H.-L. Hsieh and C.-M. Yang, “Role of redox signaling in neuroinflammation and neurodegenerative diseases,” BioMed Research International, vol. 2013, Article ID 484613, 18 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Yuan, “Drugs to cure avian influenza infection—multiple ways to prevent cell death,” Cell Death and Disease, vol. 4, no. 10, article e835, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. D. L. Carden and D. N. Granger, “Pathophysiology of ischaemia-reperfusion injury,” Journal of Pathology, vol. 190, no. 3, pp. 255–266, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. R. K. Naviaux, “Oxidative shielding or oxidative stress?” The Journal of Pharmacology and Experimental Therapeutics, vol. 342, no. 3, pp. 608–618, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Y. Aboul-Enein, P. Berczyński, and I. Kruk, “Phenolic compounds: the role of redox regulation in neurodegenerative disease and cancer,” Mini-Reviews in Medicinal Chemistry, vol. 13, no. 3, pp. 385–398, 2013. View at Google Scholar · View at Scopus
  6. C. Gorrini, I. S. Harris, and T. W. Mak, “Modulation of oxidative stress as an anticancer strategy,” Nature Reviews Drug Discovery, vol. 12, no. 12, pp. 931–947, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Jiang, S. Xiao, M. A. Khan, and M. Xue, “Defective antioxidant systems in cervical cancer,” Tumor Biology, vol. 34, no. 4, pp. 2003–2009, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Kitagishi and S. Matsuda, “Redox regulation of tumor suppressor PTEN in cancer and aging (Review),” International Journal of Molecular Medicine, vol. 31, no. 3, pp. 511–515, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Majzunova, I. Dovinova, M. Barancik, and J. Y. H. Chan, “Redox signaling in pathophysiology of hypertension,” Journal of Biomedical Science, vol. 20, no. 1, article 69, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Sgarbanti, D. Amatore, I. Celestino et al., “Intracellular redox state as target for anti-influenza therapy: are antioxidants always effective?” Current Topics in Medicinal Chemistry, vol. 14, no. 22, pp. 2529–2541, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Villanueva and R. D. Kross, “Antioxidant-induced stress,” International Journal of Molecular Sciences, vol. 13, no. 2, pp. 2091–2109, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Nastos, K. Kalimeris, N. Papoutsidakis et al., “Global consequences of liver ischemia/reperfusion injury,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 906965, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. Z.-W. Zhang, J. Cheng, F. Xu et al., “Mammal cells double their total RNAs against diabetes, ischemia reperfusion and malaria-induced oxidative stress,” Molecular Medicine, vol. 17, no. 5-6, pp. 533–541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. C. W. Chan, C. Y. Cheung, W. H. Chui et al., “Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells,” Respiratory Research, vol. 6, article 135, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. L. A. Perrone, J. K. Plowden, A. García-Sastre, J. M. Katz, and T. M. Tumpey, “H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice,” PLoS Pathogens, vol. 4, no. 8, Article ID e1000115, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Cilloniz, M. J. Pantin-Jackwood, C. Ni et al., “Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection,” Journal of Virology, vol. 84, no. 15, pp. 7613–7624, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Fukuyama and Y. Kawaoka, “The pathogenesis of influenza virus infections: the contributions of virus and host factors,” Current Opinion in Immunology, vol. 23, no. 4, pp. 481–486, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Tasaka, F. Amaya, S. Hashimoto, and A. Ishizaka, “Roles of oxidants and redox signaling in the pathogenesis of acute respiratory distress syndrome,” Antioxidants & Redox Signaling, vol. 10, no. 4, pp. 739–753, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. K. R. Short, E. J. B. V. Kroeze, R. A. M. Fouchier, and T. Kuiken, “Pathogenesis of influenza-induced acute respiratory distress syndrome,” The Lancet Infectious Diseases, vol. 14, no. 1, pp. 57–69, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Yamada, G. V. Limmon, D. Zheng et al., “Major shifts in the Spatio-Temporal distribution of lung antioxidant enzymes during influenza pneumonia,” PLoS ONE, vol. 7, no. 2, Article ID e31494, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Ueda, T. Daidoji, A. Du et al., “Highly pathogenic H5N1 avian influenza virus induces extracellular Ca2+ influx, leading to apoptosis in avian cells,” Journal of Virology, vol. 84, no. 6, pp. 3068–3078, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. P. Baines, R. A. Kaiser, N. H. Purcell et al., “Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death,” Nature, vol. 434, no. 7033, pp. 658–662, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Han, M. D. Ybanez, S. Ahmadi, K. Yeh, and N. Kaplowitz, “Redox regulation of tumor necrosis factor signaling,” Antioxidants and Redox Signaling, vol. 11, no. 9, pp. 2245–2263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. I. C. C. Low, J. Kang, and S. Pervaiz, “Bcl-2: a prime regulator of mitochondrial redox metabolism in cancer cells,” Antioxidants & Redox Signaling, vol. 15, no. 12, pp. 2975–2987, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Pauling, Vitamin C and the Common Cold, Freeman Press, San Francisco, Calif, USA, 1970.
  26. S. Lewin, Vitamin C: Its Molecular Biology and Medical Potential, Academic Press, New York, NY, USA, 1976.
  27. J. S. Bland, Vitamin C: The Future is Now (Keats Good Health Guide), McGraw-Hill Press, Columbus, Ohio, USA, 1998.
  28. J. T. A. Ely, “Ascorbic acid role in containment of the world avian flu pandemic,” Experimental Biology and Medicine, vol. 232, no. 7, pp. 847–851, 2007. View at Google Scholar · View at Scopus
  29. B. Antus and Z. Kardos, “Oxidative stress in COPD: molecular background and clinical monitoring,” Current Medicinal Chemistry, vol. 22, no. 5, pp. 627–650, 2015. View at Publisher · View at Google Scholar
  30. C. H. Wiegman, C. Michaeloudes, G. Haji et al., “Oxidative stress—induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease,” The Journal of Allergy and Clinical Immunology, 2015. View at Publisher · View at Google Scholar
  31. F. Q. Schafer and G. R. Buettner, “Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple,” Free Radical Biology & Medicine, vol. 30, no. 11, pp. 1191–1212, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. J. M. Matés, C. Pérez-Gómez, I. N. De Castro, M. Asenjo, and J. Márquez, “Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death,” International Journal of Biochemistry & Cell Biology, vol. 34, no. 5, pp. 439–458, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Watanabe, M. Tahara, and S. Todo, “The novel antioxidant edaravone: from bench to bedside,” Cardiovascular Therapeutics, vol. 26, no. 2, pp. 101–114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Hishida, “Clinical analysis of 207 patients who developed renal disorders during or after treatment with edaravone reported during post-marketing surveillance,” Clinical and Experimental Nephrology, vol. 11, no. 4, pp. 292–296, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. J. B. Schulz, N. A. Di Prospero, and K. Fischbeck, “Clinical experience with high-dose idebenone in Friedreich ataxia,” Journal of Neurology, vol. 256, no. 1, pp. 42–46, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Gutzmann, K.-P. Kühl, D. Hadler, and M. A. Rapp, “Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study,” Pharmacopsychiatry, vol. 35, no. 1, pp. 12–18, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. L. J. Thal, M. Grundman, J. Berg et al., “Idebenone treatment fails to slow cognitive decline in Alzheimer's disease,” Neurology, vol. 61, no. 11, pp. 1498–1502, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Meier and G. Buyse, “Idebenone: an emerging therapy for Friedreich ataxia,” Journal of Neurology, vol. 256, supplement 1, pp. 25–30, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. U. Singh and I. Jialal, “Alpha-lipoic acid supplementation and diabetes,” Nutrition Reviews, vol. 66, no. 11, pp. 646–657, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Tesfaye, “Advances in the management of diabetic peripheral neuropathy,” Current Opinion in Supportive and Palliative Care, vol. 3, no. 2, pp. 136–143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Voutilainen, T. Nurmi, J. Mursu, and T. H. Rissanen, “Carotenoids and cardiovascular health,” The American Journal of Clinical Nutrition, vol. 83, no. 6, pp. 1265–1271, 2006. View at Google Scholar · View at Scopus
  42. N. I. Krinsky and E. J. Johnson, “Carotenoid actions and their relation to health and disease,” Molecular Aspects of Medicine, vol. 26, no. 6, pp. 459–516, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. S. K. Osganian, M. J. Stampfer, E. Rimm, D. Spiegelman, J. E. Manson, and W. C. Willett, “Dietary carotenoids and risk of coronary artery disease in women,” The American Journal of Clinical Nutrition, vol. 77, no. 6, pp. 1390–1399, 2003. View at Google Scholar · View at Scopus
  44. K. A. Huggins, K. J. Navara, M. T. Mendonça, and G. E. Hill, “Detrimental effects of carotenoid pigments: the dark side of bright coloration,” Naturwissenschaften, vol. 97, no. 7, pp. 637–644, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. M. G. Traber, “Vitamin E regulatory mechanisms,” Annual Review of Nutrition, vol. 27, no. 1, pp. 347–362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Siekmeier, C. Steffen, and W. März, “Role of oxidants and antioxidants in atherosclerosis: results of in vitro and in vivo investigations,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 12, no. 4, pp. 265–282, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. V. A. Kirsh, R. B. Hayes, S. T. Mayne et al., “Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk,” Journal of the National Cancer Institute, vol. 98, no. 4, pp. 245–254, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. S. M. Lippman, E. A. Klein, P. J. Goodman et al., “Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT),” The Journal of the American Medical Association, vol. 301, no. 1, pp. 39–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Dallner and P. J. Sindelar, “Regulation of ubiquinone metabolism,” Free Radical Biology and Medicine, vol. 29, no. 3-4, pp. 285–294, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. U. Singh, S. Devaraj, and I. Jialal, “Coenzyme Q10 supplementation and heart failure,” Nutrition Reviews, vol. 65, no. 6, pp. 286–293, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. P. S. Sândor, L. Di Clemente, G. Coppola et al., “Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial,” Neurology, vol. 64, no. 4, pp. 71–75, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. F. L. Rosenfeldt, S. J. Haas, H. Krum et al., “Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials,” Journal of Human Hypertension, vol. 21, no. 4, pp. 297–306, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Mancuso, D. Orsucci, L. Volpi, V. Calsolaro, and G. Siciliano, “Coenzyme Q10 in neuromuscular and neurodegenerative disorders,” Current Drug Targets, vol. 11, no. 1, pp. 111–121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. G. F. Kelso, C. M. Porteous, C. V. Coulter et al., “Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties,” The Journal of Biological Chemistry, vol. 276, no. 7, pp. 4588–4596, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. M. F. Ross, G. F. Kelso, F. H. Blaikie et al., “Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology,” Biochemistry, vol. 70, no. 2, pp. 222–230, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. R. A. J. Smith, R. C. Hartley, and M. P. Murphy, “Mitochondria-targeted small molecule therapeutics and probes,” Antioxidants & Redox Signaling, vol. 15, no. 12, pp. 3021–3038, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. E. J. Gane, F. Weilert, D. W. Orr et al., “The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients,” Liver International, vol. 30, no. 7, pp. 1019–1026, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. B. J. Snow, F. L. Rolfe, M. M. Lockhart et al., “A double-blind, placebo-controlled study to assess the mitochondria- targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease,” Movement Disorders, vol. 25, no. 11, pp. 1670–1674, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. V. P. Skulachev, V. N. Anisimov, Y. N. Antonenko et al., “An attempt to prevent senescence: a mitochondrial approach,” Biochimica et Biophysica Acta, vol. 1787, no. 5, pp. 437–461, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. B. M. Winklhofer-Roob, E. Rock, J. Ribalta, D. H. Shmerling, and J. M. Roob, “Effects of vitamin E and carotenoid status on oxidative stress in health and disease. Evidence obtained from human intervention studies,” Molecular Aspects of Medicine, vol. 24, no. 6, pp. 391–402, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Capelli and G. Cysewski, ASTAXANTHIN Natural Astaxanthin: King of the Carotenoids, Cyanotech Corporation, Kailua, Hawaii, USA, 2007.
  62. P. Cusack, N. McMeniman, A. Rabiee, and I. Lean, “Assessment of the effects of supplementation with vitamin E on health and production of feedlot cattle using meta-analysis,” Preventive Veterinary Medicine, vol. 88, no. 4, pp. 229–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. M. B. Lu, Y. E. Zhang, C. F. Zhao, P. P. Zhou, and L. J. Yu, “Analysis and identification of astaxanthin and its carotenoid precursors from Xanthophyllomyces dendrorhous by high-performance liquid chromatography,” Zeitschrift für Naturforschung, vol. 65, no. 7-8, pp. 489–494, 2010. View at Google Scholar · View at Scopus
  64. W. Wu, M. B. Lu, and L. J. Yu, “Expression of carotenogenic genes and astaxanthin production in Xanthophyllomyces dendrorhous as a function of oxygen tension,” Zeitschrift für Naturforschung, vol. 66, no. 5-6, pp. 283–286, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. Nishida, E. Yamashita, and W. Miki, “Quenching activities of common hydrophilic and lipophilic antioxidants against singlet oxygen using chemiluminescence detection system,” Carotenoid Science, vol. 11, no. 6, pp. 16–20, 2007. View at Google Scholar
  66. J. S. Park, H. W. Kim, B. D. Mathison et al., “Astaxanthin uptake in domestic dogs and cats,” Nutrition & Metabolism, vol. 7, no. 1, article 52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. R. G. Fassett and J. S. Coombes, “Astaxanthin, oxidative stress, inflammation and cardiovascular disease,” Future Cardiology, vol. 5, no. 4, pp. 333–342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. R. G. Fassett and J. S. Coombes, “Astaxanthin in cardiovascular health and disease,” Molecules, vol. 17, no. 2, pp. 2030–2048, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Nakajima, Y. Inokuchi, M. Shimazawa, K. Otsubo, T. Ishibashi, and H. Hara, “Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo,” The Journal of Pharmacy and Pharmacology, vol. 60, no. 10, pp. 1365–1374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Piermarocchi, S. Saviano, V. Parisi et al., “Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study,” European Journal of Ophthalmology, vol. 22, no. 2, pp. 216–225, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. N. D'Orazio, M. A. Gammone, E. Gemello, M. De Girolamo, S. Cusenza, and G. Riccioni, “Marine bioactives: pharmacological properties and potential applications against inflammatory diseases,” Marine Drugs, vol. 10, no. 4, pp. 812–833, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. S.-J. Lee, S.-K. Bai, K.-S. Lee et al., “Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IκB kinase-dependent NF-κB activation,” Molecules and Cells, vol. 16, no. 1, pp. 97–105, 2003. View at Google Scholar · View at Scopus
  73. M. Ishiki, Y. Nishida, H. Ishibashi et al., “Impact of divergent effects of astaxanthin on insulin signaling in L6 cells,” Endocrinology, vol. 154, no. 8, pp. 2600–2612, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. X. Song, B. Wang, S. Lin et al., “Astaxanthin inhibits apoptosis in alveolar epithelial cells type II in vivo and in vitro through the ROS-dependent mitochondrial signalling pathway,” Journal of Cellular and Molecular Medicine, vol. 18, no. 11, pp. 2198–2212, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. A. P. Bolin, R. C. Macedo, D. P. Marin, M. P. Barros, and R. Otton, “Astaxanthin prevents in vitro auto-oxidative injury in human lymphocytes,” Cell Biology and Toxicology, vol. 26, no. 5, pp. 457–467, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. T. Tanaka, H. Makita, M. Ohnishi, H. Mori, K. Satoh, and A. Hara, “Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin,” Cancer Research, vol. 55, no. 18, pp. 4059–4064, 1995. View at Google Scholar · View at Scopus
  77. Y. Yasui, M. Hosokawa, N. Mikami, K. Miyashita, and T. Tanaka, “Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines,” Chemico-Biological Interactions, vol. 193, no. 1, pp. 79–87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Tanaka, M. Shnimizu, and H. Moriwaki, “Cancer chemoprevention by carotenoids,” Molecules, vol. 17, no. 3, pp. 3202–3242, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. R. Nakao, O. L. Nelson, J. S. Park, B. D. Mathison, P. A. Thompson, and B. P. Chew, “Effect of dietary astaxanthin at different stages of mammary tumor initiation in BALB/c mice,” Anticancer Research, vol. 30, no. 6, pp. 2171–2175, 2010. View at Google Scholar · View at Scopus
  80. N. M. Lyons and N. M. O'Brien, “Modulatory effects of an algal extract containing astaxanthin on UVA-irradiated cells in culture,” Journal of Dermatological Science, vol. 30, no. 1, pp. 73–84, 2002. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Santocono, M. Zurria, M. Berrettini, D. Fedeli, and G. Falcioni, “Lutein, zeaxanthin and astaxanthin protect against DNA damage in SK-N-SH human neuroblastoma cells induced by reactive nitrogen species,” Journal of Photochemistry and Photobiology B: Biology, vol. 88, no. 1, pp. 1–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. J.-P. Yuan, J. Peng, K. Yin, and J.-H. Wang, “Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae,” Molecular Nutrition & Food Research, vol. 55, no. 1, pp. 150–165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. P. Kidd, “Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential,” Alternative Medicine Review, vol. 16, no. 4, pp. 355–364, 2011. View at Google Scholar · View at Scopus
  84. P. Nagendraprabhu and G. Sudhandiran, “Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2,” Investigational New Drugs, vol. 29, no. 2, pp. 207–224, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. P. Palozza, C. Torelli, A. Boninsegna et al., “Growth-inhibitory effects of the astaxanthin-rich alga Haematococcus pluvialis in human colon cancer cells,” Cancer Letters, vol. 283, no. 1, pp. 108–117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. X.-D. Song, J.-J. Zhang, M.-R. Wang, W.-B. Liu, X.-B. Gu, and C.-J. Lv, “Astaxanthin induces mitochondria-mediated apoptosis in rat hepatocellular carcinoma CBRH-7919 cells,” Biological & Pharmaceutical Bulletin, vol. 34, no. 6, pp. 839–844, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. X. Song, M. Wang, L. Zhang et al., “Changes in cell ultrastructure and inhibition of JAK1/STAT3 signaling pathway in CBRH-7919 cells with astaxanthin,” Toxicology Mechanisms and Methods, vol. 22, no. 9, pp. 679–686, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. H. McNulty, R. F. Jacob, and R. P. Mason, “Biologic activity of carotenoids related to distinct membrane physicochemical interactions,” The American Journal of Cardiology, vol. 101, no. 10, pp. S20–S29, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. A. V. Kozlov, D. I. Egorov, I. A. Vladimirov, and O. A. Azizova, “Formation of iron complexes with ascorbic acid in physiological conditions in vitro and in tissue in vivo,” Biofizika, vol. 35, no. 3, pp. 513–517, 1990. View at Google Scholar
  90. H.-S. Kim, M. J. Quon, and J.-A. Kim, “New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate,” Redox Biology, vol. 2, no. 1, pp. 187–195, 2014. View at Publisher · View at Google Scholar · View at Scopus
  91. J. Choi, “Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic considerations,” Free Radical Biology and Medicine, vol. 52, no. 7, pp. 1135–1150, 2012. View at Publisher · View at Google Scholar · View at Scopus
  92. D. P. Vivekananthan, M. S. Penn, S. K. Sapp, A. Hsu, and E. J. Topol, “Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials,” The Lancet, vol. 361, no. 9374, pp. 2017–2023, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. A. Shuaib, K. R. Lees, P. Lyden et al., “NXY-059 for the treatment of acute ischemic stroke,” The New England Journal of Medicine, vol. 357, no. 6, pp. 562–571, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. H. M. Cochemé and M. P. Murphy, “Can antioxidants be effective therapeutics?” Current Opinion in Investigational Drugs, vol. 11, no. 4, pp. 426–431, 2010. View at Google Scholar · View at Scopus
  95. O. Firuzi, R. Miri, M. Tavakkoli, and L. Saso, “Antioxidant therapy: current status and future prospects,” Current Medicinal Chemistry, vol. 18, no. 25, pp. 3871–3888, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. J. D. Watson, “Type 2 diabetes as a redox disease,” The Lancet, vol. 383, no. 9919, pp. 841–843, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. S. K. Powers and M. J. Jackson, “Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production,” Physiological Reviews, vol. 88, no. 4, pp. 1243–1276, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Ristow, K. Zarse, A. Oberbach et al., “Antioxidants prevent health-promoting effects of physical exercise in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 21, pp. 8665–8670, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Martin-Montalvo, E. M. Mercken, S. J. Mitchell et al., “Metformin improves health span and lifespan in mice,” Nature Communications, vol. 4, no. 1, p. 2192, 2013. View at Google Scholar
  100. G. Nardai, K. Stadler, E. Papp, T. Korcsmáros, J. Jakus, and P. Csermely, “Diabetic changes in the redox status of the microsomal protein folding machinery,” Biochemical and Biophysical Research Communications, vol. 334, no. 3, pp. 787–795, 2005. View at Publisher · View at Google Scholar · View at Scopus
  101. J. C. Smith, K. A. Nielson, P. Antuono et al., “Semantic memory functional mri and cognitive function after exercise intervention in mild cognitive impairment,” Journal of Alzheimer's Disease, vol. 37, no. 1, pp. 197–215, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. A. Sujak, “Interactions between canthaxanthin and lipid membranes—possible mechanisms of canthaxanthin toxicity,” Cellular and Molecular Biology Letters, vol. 14, no. 3, pp. 395–410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. R. Goralczyk, “Beta-carotene and lung cancer in smokers: review of hypotheses and status of research,” Nutrition and Cancer, vol. 61, no. 6, pp. 767–774, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. M.-F. Chen, C.-M. Yang, C.-M. Su, J.-W. Liao, and M.-L. Hu, “Inhibitory effect of vitamin C in combination with vitamin K3 on tumor growth and metastasis of Lewis lung carcinoma xenografted in C57BL/6 mice,” Nutrition and Cancer, vol. 63, no. 7, pp. 1036–1043, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. P. Chen, J. Stone, G. Sullivan, J. A. Drisko, and Q. Chen, “Anti-cancer effect of pharmacologic ascorbate and its interaction with supplementary parenteral glutathione in preclinical cancer models,” Free Radical Biology and Medicine, vol. 51, no. 3, pp. 681–687, 2011. View at Publisher · View at Google Scholar · View at Scopus
  106. M. G. Traber and J. F. Stevens, “Vitamins C and E: beneficial effects from a mechanistic perspective,” Free Radical Biology and Medicine, vol. 51, no. 5, pp. 1000–1013, 2011. View at Publisher · View at Google Scholar · View at Scopus
  107. N. J. White, R. G. Webster, E. A. Govorkova, and T. M. Uyeki, “What is the optimal therapy for patients with H5N1 influenza?” PLoS Medicine, vol. 6, no. 6, Article ID e1000091, 2009. View at Publisher · View at Google Scholar · View at Scopus